<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02115724</url>
  </required_header>
  <id_info>
    <org_study_id>NO-Stress Pro00001887</org_study_id>
    <secondary_id>5P01HL069999</secondary_id>
    <nct_id>NCT02115724</nct_id>
  </id_info>
  <brief_title>Nitric Oxide Bioavailability and Early Life Stress (NO-Stress)</brief_title>
  <acronym>NO-Stress</acronym>
  <official_title>Effect of Low Childhood Socioeconomic Status (SES) on Adult Endothelial Function and Nitric Oxide Bioavailability in Vivo and ex Vivo</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Augusta University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Heart, Lung, and Blood Institute (NHLBI)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>Augusta University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Cardiovascular disease is the leading cause of death in the United States. Other studies have
      shown that stress, early in life, could be a risk factor for cardiovascular disease, later in
      life. This study will look at the effect of early life stressors on your cardiovascular
      health.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This study will have two parts involved to investigate the role that childhood SES status has
      on cardiovascular health.

      Part one: Subjects will give a blood sample which will be processed and analyzed. Flow
      mediated dilation (FMD) and Pulse wave velocity (PWV/PWA) will be performed at baseline and 2
      hours following either a single dose oral antioxidant cocktail (1000 mg of Vitamin C, 600 IU
      of Vitamin E, and 600 mg of alpha-lipoic acid) or placebo on two days separated by at least
      72 hours. Nitroglycerin mediated dilation (NMD, 0.4mg sub-lingual nitroglycerin spray), will
      be assessed at baseline.

      Part two: Subjects, if interested will undergo a subcutaneous gluteal/hip fat biopsy. Micro
      vessels will be isolated from the adipose tissue and analyzed by pressurized myography for
      endothelial function and nitric oxide bioavailability.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>April 2014</start_date>
  <completion_date type="Anticipated">April 2020</completion_date>
  <primary_completion_date type="Anticipated">April 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Acute Change in Flow mediated dilation</measure>
    <time_frame>Change from baseline (2 hours)</time_frame>
    <description>Flow-Mediated Dilation will be determined at baseline and 2 hours following acute antioxidant treatment</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Acute Change in Biomarkers of oxidative stress</measure>
    <time_frame>Change from baseline (2 hours)</time_frame>
    <description>Nitrite/nitrate, antioxidant capacity, and 8-isoprostane at baseline and 2 hours following acute antioxidant treatment</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Acute Change in Arterial Stiffness</measure>
    <time_frame>Change from baseline (2 hours)</time_frame>
    <description>Pulse wave velocity will be determined at baseline and 2 hours following acute antioxidant treatment</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Acute change in Flow mediated dilation</measure>
    <time_frame>Immediate</time_frame>
    <description>Nitroglycerin mediated dilation will be measured immediately following an administered 0.4mg dose of nitroglycerin spray, sub-lingual.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">340</enrollment>
  <condition>Cardiovascular Disease</condition>
  <arm_group>
    <arm_group_label>Antioxidant Cocktail</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Following an overnight fast, blood samples, flow-mediated dilation, and nitroglycerin mediated dilation (NMD; 0.4mg sub-lingual nitroglycerin spray) will be performed at baseline and 2 hours following either a single dose oral antioxidant cocktail (1000 mg Vitamin C, 600 IU vitamin E, 600 mg Alpha Lipoic Acid) or placebo on two days separated by at least 72 hours.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Biopsy</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Following an overnight fast, a subcutaneous gluteal/hip fat biopsy sample will be obtained from each subject under local anesthesia, with adipose tissue (~2x1.5x1.5cm) to be harvested and placed immediately in physiological saline solution (PSS): Small arteries, 100 to 150 um in diameter, will be dissected from the fat under a dissecting microscope, transferred to an arteriographic bath chamber, and cannulated for pressurized myography.</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Antioxidant cocktail</intervention_name>
    <description>Flow-Mediated Dilation will be determined at baseline and 2 hours following acute antioxidant treatment</description>
    <arm_group_label>Antioxidant Cocktail</arm_group_label>
    <other_name>Vitamin C</other_name>
    <other_name>Vitamin E</other_name>
    <other_name>Alpha Lipoic Acid</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Biopsy</intervention_name>
    <description>Under sterile conditions, a small incision (¼ - ½ inch) by the study doctor will be made and the piece of fat will be taken out. Fat tissue was chosen for this study because it is a big source of small blood vessels which we are studying</description>
    <arm_group_label>Biopsy</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>Flow-Mediated Dilation will be determined at baseline and 2 hours following acute antioxidant treatment</description>
    <arm_group_label>Antioxidant Cocktail</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>NMD; 0.4mg sub-lingual nitroglycerin spray</intervention_name>
    <description>Nitroglycerin mediated dilation will be measured immediately following an administered 0.4mg dose of nitroglycerin spray, sub-lingual.</description>
    <arm_group_label>Antioxidant Cocktail</arm_group_label>
    <other_name>Generic name: Nitrolingual</other_name>
    <other_name>Manufacturer: Arbor Pharmaceuticals</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  documented childhood SES

          -  men and premenopausal women ages 18-40

          -  lean/overweight/or obese with BMI&lt; or equal to 39kg/m2

        Exclusion Criteria:

          -  cardiovascular, renal, pulmonary, hepatic, cerebral, or metabolic,disease

          -  use medications that affect vascular tone

          -  post menopausal women

          -  have class 3 obesity or BMI over 40
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>40 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ryan Harris, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Augusta University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Ryan Harris, PhD</last_name>
    <phone>706 721-5998</phone>
    <email>ryharris@gru.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Jacob Looney, BA</last_name>
    <phone>706 721-5483</phone>
    <email>jlooney@gru.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Georgia Prevention Institute , Georgia Regents University</name>
      <address>
        <city>Augusta</city>
        <state>Georgia</state>
        <zip>30912</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ryan Harris, PhD</last_name>
      <phone>706-721-5998</phone>
      <email>ryharris@gru.edu</email>
    </contact>
    <contact_backup>
      <last_name>Jacob Looney, BS</last_name>
      <phone>706 721-5483</phone>
      <email>jlooney@gru.edu</email>
    </contact_backup>
    <investigator>
      <last_name>Ryan Harris, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>November 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 28, 2014</study_first_submitted>
  <study_first_submitted_qc>April 15, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 16, 2014</study_first_posted>
  <last_update_submitted>November 7, 2017</last_update_submitted>
  <last_update_submitted_qc>November 7, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">November 9, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Augusta University</investigator_affiliation>
    <investigator_full_name>Ryan Harris</investigator_full_name>
    <investigator_title>Assistant Professor</investigator_title>
  </responsible_party>
  <keyword>Low childhood SES</keyword>
  <keyword>Early Life Stress</keyword>
  <keyword>Endothelial function</keyword>
  <keyword>Flow mediated dilation</keyword>
  <keyword>Cardiovascular disease</keyword>
  <keyword>Subcutaneous adipose arterioles</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cardiovascular Diseases</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Vitamins</mesh_term>
    <mesh_term>Ascorbic Acid</mesh_term>
    <mesh_term>Vitamin E</mesh_term>
    <mesh_term>Thioctic Acid</mesh_term>
    <mesh_term>Nitric Oxide</mesh_term>
    <mesh_term>Antioxidants</mesh_term>
    <mesh_term>Nitroglycerin</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

